NEWYORK-PRESBYTERIAN/QUEENS — History
CCN 330055 | 3-year financial timeline | COVID resilience: 40/100
🛡️ Public data only — no PHI permitted on this instance.
$890M
Latest Revenue (FY2022)
+5.6%
Revenue CAGR (3yr)
-58.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $799M | $879M | $890M | +1.2% | +5.6% |
| Operating Expenses | $1.1B | $1.2B | $1.4B | +14.2% | +12.2% |
| Operating Margin | -40.6% | -40.6% | -58.7% | -44.4% | +0.0% |
| Net Income | $-324M | $-357M | $-522M | -46.2% | +0.0% |
| Licensed Beds | 476 | 476 | 476 | +0.0% | +0.0% |
| Total Patient Days | 152,918 | 163,425 | 150,090 | -8.2% | -0.9% |
| Medicare Day % | 26% | 25% | 27% | +8.1% | +0.4% |
| Medicaid Day % | 9% | 7% | 7% | -3.6% | -12.4% |
COVID Impact & Recovery
Resilience Score: 40/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +11.5% ($799M → $890M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+5.6%
This Hospital
+7.6%
State Avg
Latest Margin
-58.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $936M | -67.7% |
| FY2024 (proj) | $982M | -76.7% |
| FY2025 (proj) | $1.0B | -85.8% |